Literature DB >> 28507746

Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.

Alfredo J Lucendo1,2, Javier Molina-Infante2,3, Ángel Arias2,4, Ulrike von Arnim5, Albert J Bredenoord6, Christian Bussmann7, Jorge Amil Dias8, Mogens Bove9, Jesús González-Cervera2,10, Helen Larsson9, Stephan Miehlke11, Alexandra Papadopoulou12, Joaquín Rodríguez-Sánchez13, Alberto Ravelli14, Jukka Ronkainen15, Cecilio Santander2,16, Alain M Schoepfer17, Martin A Storr18, Ingrid Terreehorst19, Alex Straumann20, Stephen E Attwood21.   

Abstract

INTRODUCTION: Eosinophilic esophagitis (EoE) is one of the most prevalent esophageal diseases and the leading cause of dysphagia and food impaction in children and young adults. This underlines the importance of optimizing diagnosys and treatment of the condition, especially after the increasing amount of knowledge on EoE recently published. Therefore, the UEG, EAACI ESPGHAN, and EUREOS deemed it necessary to update the current guidelines regarding conceptual and epidemiological aspects, diagnosis, and treatment of EoE.
METHODS: General methodology according to the Appraisal of Guidelines for Research and Evaluation (AGREE) II and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was used in order to comply with current standards of evidence assessment in formulation of recommendations. An extensive literature search was conducted up to August 2015 and periodically updated. The working group consisted of gastroenterologists, allergists, pediatricians, otolaryngologists, pathologists, and epidemiologists. Systematic evidence-based reviews were performed based upon relevant clinical questions with respect to patient-important outcomes.
RESULTS: The guidelines include updated concept of EoE, evaluated information on disease epidemiology, risk factors, associated conditions, and natural history of EoE in children and adults. Diagnostic conditions and criteria, the yield of diagnostic and disease monitoring procedures, and evidence-based statements and recommendation on the utility of the several treatment options for patients EoE are provided. Recommendations on how to choose and implement treatment and long-term management are provided based on expert opinion and best clinical practice.
CONCLUSION: Evidence-based recommendations for EoE diagnosis, treatment modalities, and patients' follow up are proposed in the guideline.

Entities:  

Keywords:  Eosinophilic esophagitis; consensus development conferences; evidence-based practice; guidelines

Year:  2017        PMID: 28507746      PMCID: PMC5415218          DOI: 10.1177/2050640616689525

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  19 in total

1.  Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.

Authors:  Javier Molina-Infante; Lucia Ferrando-Lamana; Cristina Ripoll; Moises Hernandez-Alonso; Jose M Mateos; Miguel Fernandez-Bermejo; Carmen Dueñas; Nuria Fernandez-Gonzalez; Eva M Quintana; Maria Angeles Gonzalez-Nuñez
Journal:  Clin Gastroenterol Hepatol       Date:  2010-10-01       Impact factor: 11.382

2.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

3.  The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor.

Authors:  G Vazquez-Elizondo; S Ngamruengphong; M Khrisna; K R Devault; N J Talley; S R Achem
Journal:  Aliment Pharmacol Ther       Date:  2013-10-05       Impact factor: 8.171

4.  Results of ambulatory pH monitoring do not reliably predict response to therapy in patients with eosinophilic oesophagitis.

Authors:  D L Francis; A Foxx-Orenstein; A S Arora; T C Smyrk; K Jensen; S L Nord; J A Alexander; Y Romero; D A Katzka
Journal:  Aliment Pharmacol Ther       Date:  2011-11-24       Impact factor: 8.171

Review 5.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

6.  Comparison of eotaxin-3 biomarker in patients with eosinophilic oesophagitis, proton pump inhibitor-responsive oesophageal eosinophilia and gastro-oesophageal reflux disease.

Authors:  F J Moawad; J M Wells; R L Johnson; B J Reinhardt; C L Maydonovitch; T P Baker
Journal:  Aliment Pharmacol Ther       Date:  2015-05-24       Impact factor: 8.171

7.  Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings.

Authors:  F J Moawad; A M Schoepfer; E Safroneeva; M R Ally; Y-J Chen; C L Maydonovitch; R K H Wong
Journal:  Aliment Pharmacol Ther       Date:  2014-01-26       Impact factor: 8.171

Review 8.  Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.

Authors:  Glenn T Furuta; Chris A Liacouras; Margaret H Collins; Sandeep K Gupta; Chris Justinich; Phil E Putnam; Peter Bonis; Eric Hassall; Alex Straumann; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2007-08-08       Impact factor: 22.682

9.  ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).

Authors:  Evan S Dellon; Nirmala Gonsalves; Ikuo Hirano; Glenn T Furuta; Chris A Liacouras; David A Katzka
Journal:  Am J Gastroenterol       Date:  2013-04-09       Impact factor: 10.864

10.  Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome.

Authors:  S E Attwood; T C Smyrk; T R Demeester; J B Jones
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

View more
  205 in total

1.  Novel Therapeutic Approaches to Eosinophilic Esophagitis.

Authors:  Claire Beveridge; Gary W Falk
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-06

2.  Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study.

Authors:  Tetsuo Shoda; Ting Wen; Seema S Aceves; J Pablo Abonia; Dan Atkins; Peter A Bonis; Julie M Caldwell; Kelley E Capocelli; Christina L Carpenter; Margaret H Collins; Evan S Dellon; Michael D Eby; Nirmala Gonsalves; Sandeep K Gupta; Gary W Falk; Ikuo Hirano; Paul Menard-Katcher; Jonathan T Kuhl; Jeffrey P Krischer; John Leung; Vincent A Mukkada; Jonathan M Spergel; Michael P Trimarchi; Guang-Yu Yang; Nives Zimmermann; Glenn T Furuta; Marc E Rothenberg
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-05-03

3.  Summary of the updated international consensus diagnostic criteria for eosinophilic esophagitis: AGREE conference.

Authors:  Jonathan M Spergel; Evan S Dellon; Chris A Liacouras; Ikuo Hirano; Javier Molina-Infante; Albert J Bredenoord; Glenn T Furuta
Journal:  Ann Allergy Asthma Immunol       Date:  2018-07-18       Impact factor: 6.347

4.  Acute intramucosal dissection in eosinophilic esophagitis.

Authors:  Francesca Fianchi; Giuseppe De Matteis; Rossella Cianci; Marco Pizzoferrato; Silvia Cardone; Maria Anna Nicolazzi; Mariella Fuorlo; Maria Teresa Congedo; Vincenzo Arena; Maria Elena Riccioni; Brunella Barbaro; Giovanni Gambassi
Journal:  Clin J Gastroenterol       Date:  2019-05-03

5.  Eosinophilic esophagitis: Time to classify into endotypes?

Authors:  Anna E Ferguson; Patricia C Fulkerson
Journal:  J Allergy Clin Immunol       Date:  2018-05-08       Impact factor: 10.793

6.  Minimally invasive biomarker studies in eosinophilic esophagitis: A systematic review.

Authors:  Brittany T Hines; Matthew A Rank; Benjamin L Wright; Lisa A Marks; John B Hagan; Alex Straumann; Matthew Greenhawt; Evan S Dellon
Journal:  Ann Allergy Asthma Immunol       Date:  2018-05-16       Impact factor: 6.347

7.  Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy Research.

Authors:  Mirna Chehade; Stacie M Jones; Robbie D Pesek; A Wesley Burks; Brian P Vickery; Robert A Wood; Donald Y M Leung; Glenn T Furuta; David M Fleischer; Alice K Henning; Peter Dawson; Robert W Lindblad; Scott H Sicherer; J Pablo Abonia; Joseph D Sherrill; Hugh A Sampson; Marc E Rothenberg
Journal:  J Allergy Clin Immunol Pract       Date:  2018-08-01

8.  Longitudinal Growth Outcomes Following First-line Treatment for Pediatric Patients With Eosinophilic Esophagitis.

Authors:  Elizabeth T Jensen; Kevin Z Huang; Hannah X Chen; Lisa E Landes; Kristen A McConnell; Mary Angie Almond; Anca M Safta; Douglas T Johnston; Raquel Durban; Laura Jobe; Carrie Frost; Sarah Donnelly; Brady Antonio; Antonio Quiros; Jonathan E Markowitz; Evan S Dellon
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-01       Impact factor: 2.839

Review 9.  Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.

Authors:  Mery Munoz-Persy; Alfredo J Lucendo
Journal:  Eur J Pediatr       Date:  2018-03-17       Impact factor: 3.183

Review 10.  What Is the Relationship Between Eosinophilic Esophagitis (EoE) and Aeroallergens? Implications for Allergen Immunotherapy.

Authors:  Maureen Egan; Dan Atkins
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-16       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.